Concentrations of total serum N-acetyl-neuraminic acid, carcinoembryonic antigen, ferritin, lactate dehydrogenase, creatine phosphokinase and total proteins were measured in both tumor drainage blood (axillary vein) and in peripheral blood taken during surgery from 44 breast cancer patients.
There were no significant differences in any of the markers between mean values in peripheral and tumor drainage blood, between cancer patients and healthy controls, between patients with or without axillary lymph node metastases, or according to the site of breast mass.
SilverH.K.B., KarimK.A., SalinasF.A., SwenertonK.D.Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary.Surg Gynecol Obstet1981; 153: 209–13.
10.
Hogan-RyanA., FennellyJ.J., JonesJ., CantevellB., DuffyM.J.Serum sialic acid and CEA concentrations in human breast cancer.Br J Cancer1980; 41: 587–92.
11.
MossA.J., BissadaN.K., BoydC.M., HunterW.C.Significance of protein-bound neuraminic acid levels in patients with prostatic and bladder carcinoma.Urology1979; 13: 182–4.
12.
Mac BethR.A.L., BekasiJ.G.Plasma glycoproteins in various disease states including carcinoma.Cancer Res1962; 22: 1170–6.
13.
JohnsonA., O'ByrneP., BrowneR., CollinsP.. Sialic acid levels in peripheral and tumor draining blood in carcinoma of the colon.Third International Conference on Human Tumor Markers, Naples, Italy, April 1986; 23–6. (Abstr. P.5.4).
14.
JacobsA., JonesB., RickettsC., BulbrookR.D., WangD.Y.Serum ferritin concentrations in early breast cancer.Br J Cancer1976; 34: 286–90.
15.
MarcusD.M., ZinbergN.Measurements of serum ferritin by radioimmunoassay. Results in normal individuals and patients with breast cancer.J Natl Cancer Inst1975; 55: 791–5.
16.
WarburgO.The metabolism of tumors.LondonConstable and Co. Ldt., 1930.
17.
WarburgO., ChristianW.Garungsfermente im bluserum von tumor ratten.Biochem Ztschr1943; 314: 399–403.
18.
HakomoriS.Tumor-associated carbohydrate antigens.Annual Review of Immunology1984; 2: 103–26.
19.
DoyleP.J., NicholsonR.I., GroomeG.V., BlarneyR.W.Carcinoembryonic antigen: its role as tumor marker in breast cancer.Clinical Oncology1981; 7: 53–8.
20.
VaianiG., LocatelliE., SensalariG., MontiM., ReggianiS., CuniettiE.Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients. Individual and combined clinical usefulness as tumor markers.J Exp Clin Cancer Res1987; 6: 195–8.
21.
SacksN.P.M., StackerS.A., ThompsonC.H.. Comparison of mammary serum antigen (MSA) and CA 15-3 levels in the serum of patients with breast cancer.Br J Cancer1987; 56: 820–4.
22.
KonijnA.M., HershkoC.Ferritin synthesis in inflammation.Br J Haematol1977; 37: 7–11.
23.
CuniettiE., VaianiG., GandiniM.C.. Carcinoembryonic antigen, ferritin, anionic glycoproteins and their sialic acid content in advanced colorectal cancer.Cancer Det Prev1985; 8: 227–32.
24.
Hogan-RyanA., FennellyJ.J., JonesM., CantwellB., DuffyM.J.Serum sialic acid and CEA concentrations in human breast cancer.Br J Cancer1980; 41: 587–92.
25.
BerraB., RapelliS., MonticelliG.. Usefulness and potential pitfalls of sialic acid determination in sera of patients with ovarian tumors.Int J Biol Markers1986; 1, 1: 39–46.
26.
LorentzK., WeibT., KraasE.Sialic acid in human serum and cerebrospinal fluid. Comparison of methods and reference values.J Clin Chem Clin Biochem1986; 24: 189–98.
